Weight loss drugs (GLP 1 Agonists, Mounjaro, Ozempic etc)

We understand there has been significant media coverage regarding these drugs and their availability. We want to clarify that these medications are not currently available on demand. Our practice is awaiting the launch of an Integrated Care Board (ICB) Weight Management and Complex Obesity Service (WMCOS), which will provide comprehensive support for eligible patients. Until this service is operational, we encourage patients to continue focusing on healthy lifestyle choices and consult with us for personalised advice.